Share or Print this page
There is a global race to uncover and develop blood-based biomarkers for Alzheimer’s and other dementia, and there is a need for non-invasive tools to detect this disease in the earlier stages. Join us on June 9th from 10:30am - 12noon for our virtual 2021 Research Symposium “Early Detection Advances: An Update on Blood-Based Biomarkers”, presented by Oskar Hansson, MD, PhD, Head of the Clinical Memory Research Unit, Lund University, Sweden.

Dr. Hansson will explain recent advances in these biomarkers and how they can improve detection of early Alzheimer's Disease. He will also share how these biomarkers and others can advance clinical trials. The symposium also features Dr. Christopher van Dyke, Director, Yale Alzheimer's Disease Research Center (ADRC) and Chair of the Medical Scientific Advisory Council, Alzheimer's Association Connecticut Chapter.